ACM
HOOK

Aquatic Capital Management’s HOOKIPA Pharma HOOK Stock Holding History

Aquatic Capital Management’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-290
Closed -$7K – 1269
2021
Q4 		$7K Buy
+290
New +$11.7K 0.01% 873

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aquatic Capital Management's HOOK Position: Q1 2022 in Review

Aquatic Capital Management sold out of HOOKIPA Pharma (HOOK) in Q1 2022, closing a stake of 290 shares — an estimated $7K sold.

Aquatic Capital Management first reported a position in HOOK in Q4 2021 and held it in 1 quarter. The position peaked at $7K in Q4 2021. 74 funds tracked by Wall St. Rank hold HOOK as of Q1 2022.

  • Aquatic Capital Management reported no remaining HOOKIPA Pharma position as of Q1 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 290 HOOKIPA Pharma shares in Q1 2022, an estimated $7K.
  • Aquatic Capital Management first reported a position in HOOKIPA Pharma in Q4 2021 and held it in 1 quarter.
  • Aquatic Capital Management's HOOKIPA Pharma position peaked at $7K in Q4 2021.
  • 74 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2022.

Based on Aquatic Capital Management's 13F filing for Q1 2022, filed 16 May 2022.